Canna Farms has recalled one lot of its Tangerine Dream five gram dried cannabis sold through its medical sales channel for incorrect labelling as of August 2. 

The products were sold with incorrect cannabinoid values, where the total labelled THC and total CBD are lower than the actual total THC and total CBD values in the product.

The printed value of THC was 8.3 mg/g, while the correct amount was 3.7 mg/g. The total labelled THC was 175 mg/g, while the accurate amount was 246 mg/g. The labelled CBD was <0.15 mg/g, while the correct amount should have been <0.1. mg/g. Total CBD was labelled as 0.5 mg/g but should have been 1.4 mg/g 

Health Canada has not received any complaints related to the recall as of publication. Canna Farms Ltd. has currently received one complaint which noted that the label on the product was incorrect. Neither Canna Farms Ltd. nor Health Canada have received any adverse reaction reports for the recalled cannabis product lot.

There were 23 units of recalled product sold from May 31, 2024, to July 23, 2024, under lot number 24AER-DF1. Affected clients can contact Canna Farms directly. 

Canna Farms’ parent company, MediPharm, recently announced it was closing the Canna Farms BC facility and moving operations to Ontario.

Labelling errors remain the most common reason for cannabis product recalls in Canada.